Search Results

There are 6915 results for: content related to: Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: Long-term results from a phase 2/3 clinical trial

  1. Positive treatment effects of ustekinumab in psoriasis: Analysis of lesional and systemic parameters

    The Journal of Dermatology

    Volume 37, Issue 5, May 2010, Pages: 413–425, Manjula REDDY, Gisela TORRES, Thomas McCORMICK, Colleen MARANO, Kevin COOPER, Newman YEILDING, Yuhua WANG, Charles PENDLEY, Uma PRABHAKAR, Jackson WONG, Cuc DAVIS, Stephen XU and Carrie BRODMERKEL

    Article first published online : 9 APR 2010, DOI: 10.1111/j.1346-8138.2010.00802.x

  2. Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

    The Journal of Dermatology

    Volume 39, Issue 9, September 2012, Pages: 761–769, Hidemi NAKAGAWA, Brad SCHENKEL, Mai KATO, Takeshi KATO, Atsuyuki IGARASHI and The Japanese Ustekinumab Study Group

    Article first published online : 12 MAR 2012, DOI: 10.1111/j.1346-8138.2012.01521.x

  3. Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies

    The Journal of Dermatology

    Volume 39, Issue 8, August 2012, Pages: 730–731, Iria CASTIÑEIRAS, Luisa FERNÁNDEZ-DIAZ, Yolanda JUÁREZ and Mercedes LUEIRO

    Article first published online : 27 FEB 2012, DOI: 10.1111/j.1346-8138.2011.01499.x

  4. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

    British Journal of Dermatology

    Volume 166, Issue 4, April 2012, Pages: 861–872, A.B. Kimball, K.B. Gordon, S. Fakharzadeh, N. Yeilding, P.O. Szapary, B. Schenkel, C. Guzzo, S. Li and K.A. Papp

    Article first published online : 27 MAR 2012, DOI: 10.1111/j.1365-2133.2012.10901.x

  5. Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis: A case series

    The Journal of Dermatology

    Volume 38, Issue 11, November 2011, Pages: 1096–1099, Ting-Shun WANG and Tsen-Fang TSAI

    Article first published online : 4 MAY 2011, DOI: 10.1111/j.1346-8138.2011.01224.x

  6. You have free access to this content
    Japanese guidance for use of biologics for psoriasis (the 2013 version)

    The Journal of Dermatology

    Volume 40, Issue 9, September 2013, Pages: 683–695, Mamitaro Ohtsuki, Tadashi Terui, Akira Ozawa, Akimichi Morita, Shigetoshi Sano, Hidetoshi Takahashi, Mayumi Komine, Takafumi Etoh, Atsuyuki Igarashi, Hideshi Torii, Akihiko Asahina, Osamu Nemoto, Hidemi Nakagawa and The Biologics Review Committee of the Japanese Dermatological Association: Chair: Hidemi Nakagawa

    Article first published online : 5 SEP 2013, DOI: 10.1111/1346-8138.12239

  7. Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points

    Journal of the European Academy of Dermatology and Venereology

    Volume 28, Issue 12, December 2014, Pages: 1633–1653, L. Puig, A. López, E. Vilarrasa and I. García

    Article first published online : 19 AUG 2013, DOI: 10.1111/jdv.12238

  8. Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases

    Annals of the New York Academy of Sciences

    Volume 1182, Issue 1, December 2009, Pages: 97–110, Michael Elliott, Jacqueline Benson, Marion Blank, Carrie Brodmerkel, Daniel Baker, Kristin Ruley Sharples and Philippe Szapary

    Article first published online : 10 DEC 2009, DOI: 10.1111/j.1749-6632.2009.05070.x

  9. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 12, December 2013, Pages: 1535–1545, A.B. Kimball, K.A. Papp, Y. Wasfi, D. Chan, R. Bissonnette, H. Sofen, N. Yeilding, S. Li, P. Szapary, K.B. Gordon and on behalf of the PHOENIX 1 investigators

    Article first published online : 20 DEC 2012, DOI: 10.1111/jdv.12046

  10. Some clinical factors affecting quality of the response to ustekinumab for psoriasis

    The Journal of Dermatology

    Volume 41, Issue 8, August 2014, Pages: 690–696, Yoshinori Umezawa, Hidehisa Saeki and Hidemi Nakagawa

    Article first published online : 9 JUL 2014, DOI: 10.1111/1346-8138.12538

  11. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases

    International Journal of Dermatology

    Naomi Takahashi, Shinji Noda, Takashi Taniguchi and Makoto Adachi

    Article first published online : 27 MAY 2015, DOI: 10.1111/ijd.12859

  12. Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 7, July 2011, Pages: 851–857, L. Guenther, C. Han, P. Szapary, B. Schenkel, Y. Poulin, M. Bourcier, J.P. Ortonne and H.L. Sofen

    Article first published online : 27 APR 2011, DOI: 10.1111/j.1468-3083.2011.04082.x

  13. Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis

    Clinical and Experimental Dermatology

    Volume 39, Issue 6, August 2014, Pages: 696–707, Y. Meng, L. Dongmei, P. Yanbin, F. Jinju, T. Meile, L. Binzhu, H. Xiao, T. Ping and L. Jianmin

    Article first published online : 14 JUL 2014, DOI: 10.1111/ced.12390

  14. Drug survival rates in patients with psoriasis after treatment with biologics

    The Journal of Dermatology

    Volume 40, Issue 12, December 2013, Pages: 1008–1013, Yoshinori Umezawa, Yoshimasa Nobeyama, Mitsuha Hayashi, Osamu Fukuchi, Toshihiro Ito, Hidehisa Saeki and Hidemi Nakagawa

    Article first published online : 4 DEC 2013, DOI: 10.1111/1346-8138.12353

  15. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab

    The Journal of Dermatology

    Chihiro Nakayama, Yasuyuki Fujita, Mika Watanabe and Hiroshi Shimizu

    Article first published online : 25 MAY 2015, DOI: 10.1111/1346-8138.12943

  16. Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis

    The Journal of Dermatology

    Volume 41, Issue 11, November 2014, Pages: 974–980, Mitsuha Hayashi, Yoshinori Umezawa, Osamu Fukuchi, Toshihiro Ito, Hidehisa Saeki and Hidemi Nakagawa

    Article first published online : 25 OCT 2014, DOI: 10.1111/1346-8138.12653

  17. Population-Based Exposure-Efficacy Modeling of Ustekinumab in Patients With Moderate to Severe Plaque Psoriasis

    The Journal of Clinical Pharmacology

    Volume 50, Issue 3, March 2010, Pages: 257–267, Dr Honghui Zhou, Dr Chuanpu Hu, Dr Yaowei Zhu, Dr Ming Lu, Dr Sam Liao, Dr Newman Yeilding and Dr Hugh M. Davis

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009343695

  18. You have free access to this content
    Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 810–820, Wolfgang Weger

    Article first published online : 1 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00702.x

  19. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 89, Issue 5, October 2010, Pages: 351–363, Pauline L. Martin, Clifford Sachs, Noritaka Imai, Hideshi Tsusaki, Satoru Oneda, Qun Jiao and George Treacy

    Article first published online : 10 JUN 2010, DOI: 10.1002/bdrb.20250

  20. You have free access to this content
    The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection

    British Journal of Dermatology

    Volume 167, Issue 5, November 2012, Pages: 1145–1152, T.-F. Tsai, V. Ho, M. Song, P. Szapary, T. Kato, Y. Wasfi, S. Li, Y.K. Shen, C. Leonardi, on behalf of the PHOENIX 1, PHOENIX 2, ACCEPT, PEARL and Japanese Ustekinumab Study Groups

    Article first published online : 29 OCT 2012, DOI: 10.1111/j.1365-2133.2012.11142.x